Greiciely O. Andre

Bedford Park
Adelaide, SA 5042, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults.

Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults.

Journal: Vaccine
Published: August 22, 2024

Advax-SM™-Adjuvanted COBRA (H1/H3) Hemagglutinin Influenza Vaccines.

Advax-SM™-Adjuvanted COBRA (H1/H3) Hemagglutinin Influenza Vaccines.

Journal: Vaccines
Published: February 08, 2024

An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice.

An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice.

Journal: Vaccine
Published: May 30, 2023

Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage.

Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage.

Journal: PloS one
Published: April 23, 2023

An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge.

An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge.

Journal: Vaccine
Published: January 18, 2023

Ability of SpikoGen®, an Advax-CpG adjuvanted recombinant spike protein vaccine, to induce cross-neutralising antibodies against SARS-CoV-2 variants.

Ability of SpikoGen®, an Advax-CpG adjuvanted recombinant spike protein vaccine, to induce cross-neutralising antibodies against SARS-CoV-2 variants.

Journal: Immunology
Published: January 15, 2023

Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trial.

Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trial.

Journal: Immunology
Published: April 11, 2022

Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis.

Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis.

Journal: Vaccine
Published: December 11, 2020

The long search for a serotype independent pneumococcal vaccine.

The long search for a serotype independent pneumococcal vaccine.

Journal: Expert review of vaccines
Published: January 07, 2020

Immunization with PhtD truncated fragments reduces nasopharyngeal colonization by Streptococcus pneumoniae.

Immunization with PhtD truncated fragments reduces nasopharyngeal colonization by Streptococcus pneumoniae.

Journal: Vaccine
Published: November 22, 2019

Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.

Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.

Journal: Frontiers in microbiology
Published: June 27, 2016

Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing.

Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing.

Journal: Microbial pathogenesis
Published: November 24, 2014
Showing 1-12 of 12

Last Updated: 09/26/2026